Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor.

Lisa N Van Der Vorm,Mark Roest,Bas De Laat,Jasper A Remijn,Hilde Kelchtermans,Li Li,Walid Chayouâ,Philip G De Groot,Dana Huskens,Pablo Garcia De Frutos

doi:10.1371/journal.pone.0211961

Abstract

BackgroundInteraction of von Willebrand factor (VWF) with platelets requires a conformational change that exposes an epitope within the VWF A1 domain, enabling platelet glycoprotein Ibα binding. Quantification of this ‘‘active” conformation of VWF has been shown to provide pathophysiological insight into conditions characterized by excessive VWF-platelet interaction.MethodsWe developed an immunosorbent assay based on a variable heavy chain antibody fragment against the VWF A1 domain as a capture antibody. Assay performance in terms of specificity (binding to active R1306W- and sheared VWF), precision, accuracy, linearity, limits of detection and stability were determined. Active VWF, VWF antigen, VWF ristocetin cofactor activity, VWF:GP1bM and VWF propeptide were measured in citrated plasma and platelet-VWF binding in whole blood from 120 healthy individuals to establish a reference interval for active VWF and to assess associations with other VWF parameters.ResultsIntra- and inter-assay CVs were between 2.4–7.2% and 4.1–9.4%, depending on the level. Mean recovery of spiked recombinant R1306W VWF was 103±3%. The assay was linear in the range of 90.1–424.5% and had a limit of quantification of 101%. The reference interval for active VWF was 91.6–154.8% of NPP. Significant, positive correlations between active VWF and all other VWF parameters were found, with the strongest correlation with VWF:GP1bM binding.ConclusionsWe developed and validated an immunosorbent assay for the accurate detection of active VWF levels in plasma. The assay fulfilled all analytical criteria in this study and a reference interval was established, allowing its use to quantify active VWF in pathological conditions for future research.

Highlights

Von Willebrand factor (VWF) is a multimeric plasma protein that mediates platelet adhesion and platelet-platelet interactions [1]
Active VWF, VWF antigen, VWF ristocetin cofactor activity, VWF:GP1bM and VWF propeptide were measured in citrated plasma and plateletVWF binding in whole blood from 120 healthy individuals to establish a reference interval for active VWF and to assess associations with other VWF parameters
We developed and validated an immunosorbent assay for the accurate detection of active VWF levels in plasma

Summary

Introduction

Von Willebrand factor (VWF) is a multimeric plasma protein that mediates platelet adhesion and platelet-platelet interactions [1]. VWF binds via its A3 domain to exposed subendothelial collagen at sites of vascular injury. Circulating VWF can only exert this function after conversion from its latent, globular conformation to an active conformation, in which the binding site for platelet GpIbα is exposed. VWF immobilization to subendothelial collagen in conjunction with increased shear stress induce VWF unfolding [3], allowing for platelet-VWF interaction [4]. Interaction of von Willebrand factor (VWF) with platelets requires a conformational change that exposes an epitope within the VWF A1 domain, enabling platelet glycoprotein Ibα binding. Quantification of this ‘‘active” conformation of VWF has been shown to provide pathophysiological insight into conditions characterized by excessive VWF-platelet interaction.

Objectives

Methods

Results

Conclusion